26.12.2014 Views

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

VIII. Ketogenesis and Ketosis<br />

97<br />

possibly increased incidence <strong>of</strong> atherosclerosis was<br />

observed in the latter.<br />

C. Feline Fasting Hyperlipidemias<br />

Not surprisingly, some <strong>of</strong> the same diseases that are associated<br />

with hyperlipidemia in dogs are associated with<br />

hyperlipidemia in domestic cats, including diabetes and<br />

nephrotic syndrome ( Jones, 1995 ; McCullagh, 1978 ;<br />

Watson and Barrie, 1993 ). Some cats, however, have a<br />

well-characterized familial hyperlipidemia because <strong>of</strong> lipoprotein<br />

lipase deficiency ( Brooks, 1989 ; Jones, 1993, 1995 ;<br />

Jones et al ., 1983 ; Watson et al ., 1992b ; Whitney, 1992 ).<br />

There is lipemia with hyperchylomicronemia and increases<br />

in plasma levels <strong>of</strong> cholesterol and triacylglycerol ( Jones,<br />

1993, 1995 ; Whitney, 1992 ). The high plasma levels <strong>of</strong> lipids<br />

lead to deposition in tissues (xanthoma formation) in<br />

the skin, nerve sheaths, and other locations ( Jones, 1993 ;<br />

Whitney, 1992 ). Pressure on spinal or other nerves from<br />

xanthomas or subsequent granulomas may lead to peripheral<br />

neuropathy ( Jones et al ., 1986 ). The disease appears<br />

to be autosomal recessive, and homozygotes apparently<br />

manufacture a defective lipoprotein lipase and do not have<br />

a defective or missing apolipoprotein C-II activator ( Peritz<br />

et al ., 1990 ; Watson et al ., 1992b ).<br />

D. Equine Fasting Hyperlipidemia<br />

The phenomenon <strong>of</strong> equine hyperlipidemia was reported in<br />

horses with maxillary myositis ( Hadlow, 1962 ) and equine<br />

infectious anemia ( Gainer et al ., 1966 ). It is likely that the<br />

hyperlipidemia described in these early reports was due to<br />

anorexia, and it has been shown that fasting alone causes<br />

hyperlipidemia in horses and that pregnancy, lactation, and<br />

obesity accentuate the effect ( Eriksen and Simesen, 1970 ;<br />

Schotman and Kroneman, 1969 ; Schotman and Wagenaar,<br />

1969 ; Schotman and Wensing, 1977 ). Total plasma triacylglycerol<br />

may increase from a normal fed value <strong>of</strong> less<br />

than 500 mg/l to more than 2000 mg/l ( Morris et al ., 1972 ;<br />

Naylor et al ., 1980 ) and, in severe cases, may exceed<br />

10,000 mg/l ( Freestone et al ., 1991 ; Naylor et al ., 1980 ;<br />

Schotman and Wensing, 1977 ). Although most horses are<br />

susceptible to this effect <strong>of</strong> calorie deprivation, it is harmless<br />

for the majority, and only becomes pathological for a<br />

few. Ponies and females are more susceptible to the pathological<br />

syndrome, which can be fatal ( Hughes et al ., 2004 ).<br />

Survival rates are inversely proportional to plasma triacylglycerol<br />

concentrations ( Schotman and Wagenaar, 1969 ),<br />

and severe fatty liver and increased plasma levels <strong>of</strong> liver<br />

enzymes have been reported ( Schotman and Wagenaar,<br />

1969 ). Like in other mammals, fasting increases plasma<br />

levels <strong>of</strong> LCFA in horses and ponies ( Baetz and Pearson,<br />

1972 ; Naylor et al ., 1980 ; Watson et al ., 1992a ), and the<br />

hyperlipidemia in horses and ponies is due to increased<br />

VLDL levels ( Bauer, 1983 ; Morris et al ., 1972 ; Watson<br />

et al ., 1992a ). Presumably, horse liver is removing LCFA<br />

from plasma and reesterifying them into triacylglycerol,<br />

which are released to the plasma as VLDL. It appears that<br />

the liver <strong>of</strong> fasting horses has a high capacity for reesterification<br />

<strong>of</strong> LCFA into triacylglycerol, which is exported<br />

as VLDL. Horses do have increased plasma ketone levels<br />

when fasting ( Rose and Sampson, 1982 ), so some <strong>of</strong><br />

the LCFA removed from plasma by liver are converted to<br />

ketones, but additional LCFA are reesterified to glycerol<br />

and are recycled to the plasma as triacylglycerol in VLDL.<br />

The mechanism <strong>of</strong> fasting equine lipemia is uncertain;<br />

it could be increased secretion or decreased uptake<br />

<strong>of</strong> VLDL or a combination there<strong>of</strong>. In one study, fasting<br />

horses were injected with Triton WR 1339, a compound<br />

shown to inhibit lipoprotein lipase in rats, and the rate <strong>of</strong><br />

increase in plasma triacylglycerol levels was observed<br />

( Morris et al ., 1972 ) and compared with the preinjection<br />

level <strong>of</strong> triacylglycerol. The authors claimed that the rate<br />

<strong>of</strong> increase was not related to the level <strong>of</strong> triacylglycerol<br />

concentration. However, only four horses were used, which<br />

may not have been enough given the high variation in fasting<br />

triacylglycerol levels observed among them. On close<br />

examination <strong>of</strong> the data, it is apparent that three horses<br />

showed a perfect rank correlation <strong>of</strong> fasting triacylglycerol<br />

level and rate <strong>of</strong> triacylglycerol increase after Triton injection,<br />

with the fourth being a considerable outlier to the<br />

trend. In addition, the dose <strong>of</strong> Triton was such that all the<br />

horses developed anemia because <strong>of</strong> intravascular hemolysis.<br />

Thus, elucidation <strong>of</strong> the mechanism <strong>of</strong> fasting equine<br />

lipemia will have to await additional kinetic or enzyme<br />

studies.<br />

There are reports <strong>of</strong> apparent therapeutic success with<br />

intravenous glucose and oral carbohydrates ( Dunkel and<br />

McKenzie, 2003 ; Durham, 2006 ; Hallebeek and Beynen,<br />

2001; Mogg and Palmer, 1995 ; Watson and Love, 1994 ).<br />

This therapy makes sense in that increasing plasma glucose<br />

levels should lead to increased insulin and decreased<br />

glucagon levels, which should inhibit lipolysis in adipose<br />

which is generating plasma LCFA used for triglyceride<br />

synthesis. In addition, the hormonal changes may stimulate<br />

lipoprotein lipase activity. Although supplemental insulin<br />

has been used with carbohydrate therapy, its efficacy and<br />

safety have not been adequately evaluated, and one report<br />

indicates that hyperlipemic horse have hyperinsulinemia as<br />

well ( Oikawa et al ., 2006 ).<br />

VIII. KETOGENESIS AND KETOSIS<br />

A. Introduction<br />

The ketones or ketone bodies, which are composed <strong>of</strong><br />

acetoacetic acid, 3-hydroxybutyric acid (also known as

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!